The 49th Annual Educational Conference hosted by the National Cancer Registrars Association (NCRA) will be held May 7-10, 2023 in San Diego at the Town and Country Resort.
The post NCRA 2023 Conference appeared first on Cancer Registrar.
]]>The 49th Annual Educational Conference hosted by the National Cancer Registrars Association (NCRA) will be held May 7-10, 2023 in San Diego at the Town and Country Resort. This year’s event will be a hybrid venue, i.e., live attendance with access to live streaming and on-demand sessions after the conference. Virtual attendees will be able to attend the live sessions and present questions online during the Q&A.
The conference will feature important cancer registry topics focusing on current issues and trends in the cancer registry profession. Registrars can earn up to 20+ continuing education (CE) credits to use in maintaining their credentials.
Why should you attend?
Click on any of the links below to access conference registration, hotel and session information:
Come “Sailing Towards New Horizons” with your friends and cancer registry professional association in May. Looking forward to seeing you in San Diego!
The post NCRA 2023 Conference appeared first on Cancer Registrar.
]]>NAACCR released the 2023 updates to the ICD-O-3 histology and behavior codes. All Registrars, regardless of which type of facility, should become familiarw with the proposed changes and guidelines and coordinate with your software vendor updates to their software and edits metafiles.
The post 2023 Updates to ICD-O-3 appeared first on Cancer Registrar.
]]>8/22/2022 – NAACCR has released the 2023 updates to the ICD-O-3 histology and behavior codes. All Registrars, regardless of which type of facility, should become familiarw with the proposed changes and guidelines and coordinate with your software vendor updates to their software and edits metafiles.
To download the files (at no charge), click here ICD O 3 Coding Updates – NAACCR. Updates are available in PDF and Excel file formats. Code lists are available in numeric and alpha tables. Also available is an annotated histology list with descriptions. Be sure to read the Coding Guidelines document for the summary of changes and how updates will be implemented and the rationale for doing so.
The post 2023 Updates to ICD-O-3 appeared first on Cancer Registrar.
]]>Cancer Registrars collect and analyze data to tell a story about the latest trends in their facility, region, state or nationally. Understanding how the statistics are derived and calculated, especially if you are going to compare your hospital with another program, state or national benchmark is very important.
The post What Are Cancer Statistics? appeared first on Cancer Registrar.
]]>Cancer Registrars collect and analyze data to tell a story about the latest trends in their facility, region, state or nationally. Understanding how the statistics are derived and calculated, especially if you are going to compare your hospital with another program, state or national benchmark is very important.
SEER (Surveillance, Epidemiology and End Results) has made available a series of online videos called Did You Know? The video’s highlight key topics and trends and are helpful in understanding cancer-related statistics.
Here is one of these videos, titled “Cancer Statistics.”
The post What Are Cancer Statistics? appeared first on Cancer Registrar.
]]>When is chronic lymphocytic leukemia (CLL) in remission? What does it mean when the medical record states the CLL patient has a complete or partial remission? All great questions often heard around the table when cancer registrars get together. This article briefly describes the types of remission and the laboratory studies and tests used to determine its status.
The post When is CLL in Remission? appeared first on Cancer Registrar.
]]>When is chronic lymphocytic leukemia (CLL) in remission? What does it mean when the medical record states the CLL patient has a complete or partial remission? All great questions often heard around the table when cancer registrars get together.
CLL is the most common type of leukemia in the United States in American adults. Over 175,000 men and women are currently living with CLL, and many of them with a good quality of life. While a cure is not yet available there are a wide-range of effective treatments available today. For patients with slow-growing disease or who are in clinical remission, they may not even require active therapy. Of course, Cancer Registrars will be looking for all of this information and coding it appropriately in the case abstract.
Standard treatment for CLL is chemotherapy and radiation. However, newer treatments are being tested and made available to patients to help them achieve partial and complete remission for longer and longer periods of time. Newer therapies include:
There are two types CLL remission which we will describe below:
Laboratory tests are an important part of the medical record that the Cancer Registrar must review. For CLL you should look at the following:
CLL can be in remission for many years, but there is always a chance it could come back. It is not uncommon for a physician to recommend a “watch and wait” form of long-term surveillance. This is why it is so important for the Cancer Registrar to understand the disease process and to gather accurate and complete follow-up and cancer status information throughout the patient’s lifetime.
Cancer Registrar’s should consult the SEER hematologic coding and abstracting resources to determine other steps or actions taken during the case abstraction process, whether they are in a SEER-designated State or not.
Disclaimer – this article is not used to determine coding or abstracting standrds! Rather it is an informational guide to help the Registrar understand what they may find in the medical record. For coding or abstracting standards please refer to your apppropriate manuals.
The post When is CLL in Remission? appeared first on Cancer Registrar.
]]>